Company Filing History:
Years Active: 2007-2022
Title: The Innovative Contributions of Palaniswami Rathanaswami
Introduction
Palaniswami Rathanaswami is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. With a total of 14 patents to his name, Rathanaswami's work has the potential to impact therapeutic and diagnostic applications in medicine.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof." This invention focuses on novel antibodies that target deletion mutants of the epidermal growth factor receptor, specifically the type III deletion mutant known as EGFRvIII. The patent also encompasses human monoclonal antibodies directed against these deletion mutants, along with diagnostic and therapeutic formulations and immunoconjugates.
Career Highlights
Rathanaswami has had a distinguished career, working with prominent companies in the biotechnology sector. He has been associated with Amgen Fremont Inc. and Amgen Inc., where he has contributed to various innovative projects. His expertise in antibody development has positioned him as a key figure in his field.
Collaborations
Throughout his career, Rathanaswami has collaborated with several professionals, including Jaspal Singh Kang and Orit Foord. These collaborations have further enhanced his research and development efforts in biotechnology.
Conclusion
Palaniswami Rathanaswami's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in medical diagnostics and therapeutics.